Abstract
Aim of this study was to verify whether Mueller-Hinton agar supplemented with 2 % glucose and methylene blue (MH-GM), which is used for disk diffusion susceptibility testing of Candida species by the Clinical and Laboratory Standards Institute, is suitable for testing Malassezia pachydermatis. A variant of the disk diffusion procedure utilizing a 9-mm tablet was used to test 31 isolates against clotrimazole and miconazole using MH-GM as test medium. The MH-GM agar optimally supported the growth of all M. pachydermatis isolates, provided that the yeast inoculum was prepared with a lipid source (Tween 40 and 80). Zone edges were frequently definite and clear, facilitating the measurement of zone size and minimizing subjectivity. The inhibition zones correlated with MIC values obtained in a broth dilution assay. The agar diffusion method with MH-GM as the test medium appears as a suitable procedure for testing the susceptibility of M. pachydermatis to CTZ and MCZ in clinical laboratories. This test format may allow processing a large number of isolates in epidemiological studies. This may in turn facilitate clarifying to what extent the problem “drug resistance” accounts for cases of treatment failure in dogs with Malassezia otitis and dermatitis.
References
Chen TA, Hill PB. The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol. 2005;16:4–26.
Negre A, Bensignor E, Guillot J. Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. Vet Dermatol. 2009;20:1–12.
Bernardo FM, Martins HM, Martins ML. A survey of mycotic otitis externa of dogs in Lisbon. Rev Iberoam Micol. 1998;15:163–5.
Lorenzini R, Mercantini R, De Bernardis F. In vitro sensitivity of Malassezia spp. to various antimycotics. Drugs Exp Clin Res. 1985;11:393–5.
Nascente PDS, Nobre MDO, Schuch LF, Lucia-Júnior T, Ferreiro L, Meireles MCA. Evaluation of Malassezia pachydermatis antifungal susceptibility using two different methods. Braz J Microbiol. 2003;34:359–62.
Rougier S, Borell D, Pheulpin S, Woehrlé F, Boisramé B. A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa. Vet Dermatol. 2005;16:299–307.
Chiavassa E, Tizzani P, Peano A. In vitro antifungal susceptibility of Malassezia pachydermatis strains isolated from dogs with chronic and acute otitis externa. Mycopathologia. 2014;178:315–9.
Kiss G, Radványi S, Szigeti G. New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. J Small Anim Pract. 1997;38:51–6.
Lyskova P, Vydrzalova M, Mazurova J. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. J Vet Med A Physiol Pathol Clin Med. 2007;54:559–63.
Peano A, Beccati M, Chiavassa E, Pasquetti M. Evaluation of the antifungal susceptibility of Malassezia pachydermatis to clotrimazole, miconazole and thiabendazole using a modified CLSI M27-A3 microdilution method. Vet Dermatol. 2012;23:131–5.
CLSI. Reference method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline-second edition. CLSI document M44-A2, 2009.
CLSI. reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3, 2008.
Johnson EM. Issues in antifungal susceptibility testing. J Antimicrob Chemother. 2008;61(Suppl 1):13–8.
Schmidt A. In vitro activity of climbazole, clotrimazole and silver-sulphadiazine against isolates of Malassezia pachydermatis. J Vet med B. 1997;44:193–7.
Rincón S, de García MC, Espinel-Ingroff A. A modified Christensen’s urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole. J Clin Microbiol. 2006;44:3429–31.
Prado MR, Brito EHS, Brilhante RSN, Cordeiro RA, Leite JJG, Sidrim JJC, et al. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis. J Microbiol Methods. 2008;75:341–3.
Pietschmann S, Hoffmann K, Voget M, Pison U. Synergistic effects of miconazole and polymyxin B on microbial pathogens. Vet Res Commun. 2009;33:489–505.
Nakano Y, Wada M, Tani H, Sasai K, Baba E. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa. J Vet Med Sci. 2005;67:1243–7.
Jesus FPK, Lautert C, Zanette RA, Mahl DL, Azevedo MI, Machado MLS, et al. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Vet Microbiol. 2011;152:161–4.
Hensel P, Austel M, Wooley RE, Keys D, Ritchie BW. In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. Vet Dermatol. 2009;20:429–34.
Garau M, Pereiro M, del Palacio A. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother. 2003;47:2342–4.
Cafarchia C, Figueredo LA, Favuzzi V, Surico MR, Colao V, Iatta R, et al. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol. Vet Microbiol. 2012;159:536–40.
Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions. Vet Microbiol. 2012;155:395–8.
Brito EHS, Fontenelle ROS, Brilhante RSN, Cordeiro RA, Soares Júnior FA, Monteiro AJ, et al. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs. Vet J. 2007;174:147–53.
Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 2002;46:1781–4.
Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol. 2007;45:569–87.
Yurayart C, Nuchnoul N, Moolkum P, Jirasuksiri S, Niyomtham W, Chindamporn A, et al. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin. Med Mycol. 2013;51:721–30.
Espinel-Ingroff A. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol. 2006;44:3616–22.
Cantón E, Espinel-Ingroff A, Pemán J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther. 2009;7:107–19.
Hoeprich PD, Finn PD. Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis. 1972;126:353–61.
Hoeprich PD, Huston AC. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis. 1976;134:336–41.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Rights and permissions
About this article
Cite this article
Pasquetti, M., Chiavassa, E., Tizzani, P. et al. Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium. Mycopathologia 180, 153–158 (2015). https://doi.org/10.1007/s11046-015-9913-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-015-9913-2